The global number of COVID-19 cases and deaths has fallen for the sixth week in a row, marking a sharp downward trend in the pandemic. So much so, in fact, that many countries are planning a return to something resembling “normality” by June or July.
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
People with a history of severe allergic reactions should not get the Pfizer / Bioanth vaccine. This recommendation includes carriers of people who have been allergic to drugs, food or vaccines in the past. Those who have been shown to be allergic to the Pfizer vaccine have been treated and recovered. Allergic reactions are usually rare, but can occur with certain vaccines, such as the annual flu shot.
Blood type seems to be a predictor of how susceptible a person is to contracting SARS-CoV-2, though scientists haven't found a link between blood type per se and severity of disease.
Recent Comments